Riskpilot← Back to searchSign inGet full accessPfizer Innovations AB
ABDissolvedOrg 5569868002Wholesale of pharmaceutical and medical goods · NACE 4646Est. 201477 employees
Revenue 2020
SEK 890,3M
-5% vs 2019
EBITDA margin
3.6%
-24% vs 2019
Equity ratio
6.9%
Financial strength
Net profit 2020
SEK 24,9M
-19% vs 2019
| Revenue | SEK 890,3M | -5% |
| EBITDA | SEK 32,4M | -24% |
| Net profit | SEK 24,9M | -19% |
| Total assets | SEK 801,7M | +64% |
| Equity | SEK 55,7M | +81% |
| Employees | 77 | — |
Legal name
Pfizer Innovations AB
Org number
5569868002
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
17 oktober 2014
Share capital
SEK 0
Employees
77 (FTE)
VAT registered
No
Audit selected
No
Last report
2020-11-30
Financial year
January – December
Company purpose
Bolaget har till föremål för sin verksamhet att bedriva upplysning, annonsering och reklam rörande läkemedel och andra kemiska produkter samt bedriva tillverkning av och idka handel med sådana varor.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 |
|---|---|---|---|---|---|---|
| Revenue | — | 1 246 715 | 781 655 | 900 345 | 941 926 | 890 268 |
| Staff expenses | — | — | — | — | — | — |
| EBITDA | 21 406 | 51 394 | 38 995 | 133 327 | 42 423 | 32 397 |
| Depreciation & amort. | — | — | — | — | — | — |
| EBIT | 21 406 | 51 394 | 38 995 | 133 327 | 42 423 | 32 397 |
| Net financials | 25 | 107 | 47 | — | 14 | 9 |
| Profit before tax | 21 431 | 51 501 | 39 042 | 133 327 | 42 437 | 32 406 |
| Tax | −4 923 | −11 892 | −8 640 | −5 072 | −11 692 | −7 516 |
| Net profit | 16 508 | 39 609 | 30 402 | 128 255 | 30 745 | 24 890 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 |
|---|---|---|---|---|---|---|
| Total assets | 488 915 | 416 019 | 442 914 | 711 177 | 487 525 | 801 701 |
| Equity | 190 183 | 229 792 | 260 194 | 158 707 | 30 795 | 55 685 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 298 732 | 186 227 | 182 720 | 552 470 | 456 730 | 746 017 |
| Total debt | 298 732 | 186 227 | 182 720 | 552 470 | 456 730 | 746 017 |
EBITDA margin
3.6%
This company
15.8%
Market median
-77% vs market
20152020
Equity ratio
6.9%
This company
38.2%
Market median
-82% vs market
20152020
Return on equity
44.7%
This company
18.4%
Market median
+143% vs market
20152020
Net profit margin
2.8%
This company
8.1%
Market median
-65% vs market
20152020
Asset turnover
1.11×
This company
1.12×
Market median
+1% vs market
20152020
Debt / equity
13.40×
This company
0.62×
Market median
-2061% vs market
20152020
- Annual report 2020Filed via Bolagsverket / SCB · Period 2019-12-01 – 2020-11-30
- Annual report 2019Filed via Bolagsverket / SCB · Period 2018-12-01 – 2019-11-30
- Annual report 2018Filed via Bolagsverket / SCB · Period 2017-12-01 – 2018-11-30
- Annual report 2017Filed via Bolagsverket / SCB · Period 2016-12-01 – 2017-11-30
- Annual report 2016Filed via Bolagsverket / SCB · Period 2015-12-01 – 2016-11-30
- Annual report 2015Filed via Bolagsverket / SCB · Period 2014-12-01 – 2015-11-30
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
DJ Chief Auditor | Chief Auditor | 2020 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2020 | — | — | |
| Chairman | 2021 | — | — | |
| Board of Directors | 2021 | — | — | |
| Deputy Board Member | 2020 | — | — | |
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2020 | — | — | |
| Deputy Board Member | 2022 | — | — | |
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2020 | — | — | |
| Deputy Board Member | 2020 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Pfizer Innovations AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Duane John Swanson | Chief Auditor | 0 companies |
| Malin Kristina Parkler | Chairman | 0 companies |
| Freddie Marcus Stjernström | Chairman | 0 companies |
| Annika Märta Elisabeth Alinder | Board of Directors | 0 companies |
| Per-Arne Brånsgård | Deputy Board Member | 0 companies |
| Karl John Hermansson | Board of Directors | 0 companies |
| Katri Suvi Tuuli Svennas | Board of Directors | 0 companies |
| Christoph Martin Hermann Varenhorst | Board of Directors | 0 companies |
| Lars Magnus Christian Gerdesköld | Deputy Board Member | 0 companies |
| Christine Marie Tucker | Board of Directors | 0 companies |
| Tobias Jarmer | Board of Directors | 0 companies |
| Thomas Sigvard Bye | Board of Directors | 0 companies |
| Anna Winlöf | Board of Directors | 0 companies |
| Klas Johan Bolander | Board of Directors | 0 companies |
| L M Christian Gerdesköld Rappe | Deputy Board Member | 0 companies |